Determination of miglitol chromatography/tandem in human plasma by liquid mass spectrometry

被引:23
作者
Li, Xin
Wang, Yingwu
Wang, Jiang
Fawcett, J. Paul
Zhao, Limei
Gu, Jingkai [1 ]
机构
[1] Jilin Univ, Coll Life Sci, Res Ctr Drug Metab, Changchun 130023, Peoples R China
[2] Univ Otago, Sch Pharm, Dunedin, New Zealand
[3] Chinese Med Univ, Second Clin Hosp Affiliated, Shenyang 110004, Peoples R China
关键词
D O I
10.1002/rcm.2822
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A rapid and sensitive method for the determination of miglitol in human plasma using voglibose as internal standard has been developed and validated. Samples of plasma were deproteinated with acetonitrile and washed with dichloromethane before being analyzed by reversed-phase high-performance liquid chromatography (HPLC). Separation was carried out on a short Nucleosil C-18 column (5 mu m, 50 X 4.6 mm i.d.) using 10 mmol/L ammonium acetate at 1.0 mL/min as mobile phase. The detector was an Applied Biosystems Sciex API 4000 mass spectrometer using atmospheric pressure chemical ionization (APCI) for ion production. The instrument was operated at unit resolution in the multiple reaction monitoring mode. The assay was linear over the range 5.00-2000 ng/mL with a limit of detection of 1.00 ng/mL. Intra- and inter-day precision were < 2.82% and < 2.92%, respectively, with accuracy of 93.3-106%. The assay was successfully applied to a clinical pharmacokinetic study of miglitol given as a single oral dose (50 mg) to healthy volunteers. Copyright (c) 2006 John Wiley & Sons, Ltd.
引用
收藏
页码:247 / 251
页数:5
相关论文
共 14 条
[1]  
Ahr HJ, 1997, ARZNEIMITTEL-FORSCH, V47, P734
[2]   Acarbose: Its role in the treatment of diabetes mellitus [J].
Campbell, LK ;
White, JR ;
Campbell, RK .
ANNALS OF PHARMACOTHERAPY, 1996, 30 (11) :1255-1262
[3]   EFFECTS OF PROLONGED (6 MONTHS) ALPHA-GLUCOSIDASE INHIBITION ON BLOOD-GLUCOSE CONTROL AND INSULIN REQUIREMENTS IN PATIENTS WITH INSULIN-DEPENDENT DIABETES-MELLITUS [J].
DIMITRIADIS, G ;
KARAISKOS, C ;
RAPTIS, S .
HORMONE AND METABOLIC RESEARCH, 1986, 18 (04) :253-255
[4]  
HEINZ G, 1989, EUR J CLIN PHARMACOL, V37, P33
[5]   EFFECTS OF THE CARBOHYDRASE INHIBITOR MIGLITOL IN SULFONYLUREA-TREATED NIDDM PATIENTS [J].
JOHNSTON, PS ;
SANTIAGO, JV ;
CONIFF, RF ;
PISUNYER, FX ;
HOOGWERF, BJ ;
KROL, A .
DIABETES CARE, 1994, 17 (01) :20-29
[6]   THE EFFECT OF MIGLITOL AND ACARBOSE AFTER AN ORAL GLUCOSE-LOAD - A NOVEL HYPOGLYCEMIC MECHANISM [J].
JOUBERT, PH ;
VENTER, HL ;
FOUKARIDIS, GN .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 30 (03) :391-396
[7]  
Lebovitz H E, 1992, Drugs, V44 Suppl 3, P21
[8]  
Mitrakou A, 1998, DIABETIC MED, V15, P657, DOI 10.1002/(SICI)1096-9136(199808)15:8<657::AID-DIA652>3.0.CO
[9]  
2-7
[10]  
Nirogi RVS, 2006, ARZNEIMITTEL-FORSCH, V56, P328